V Bichko
CSO
Chroma therapeutics
Chroma International Pvt. Ltd
Russian Federation
Biography
Dr. Bichko is a virologist with over 15 years of antiviral drug discovery and development experience, mainly in the field of viral hepatitis B, C and HIV. Previously, Dr. Bichko was CSO at Viriom, Inc., a late stage HIV therapy development company (San Diego, CA), Director of Research at Idenix (valopicitabine development for HCV), Virology Lead at Scriptgen/Anadys (discovery and development of HBV polymerase and pregenomic RNA encapsidation inhibitors). Prior to that, he held various academic positions at Fox Chase Cancer Center in Philadelphia, Max-Plank Institute for Biochemistry in Munich and University of Hamburg, Germany, conducting HBV and HDV research. He is the author of numerous publications and patents in molecular virology.
Research Interest
Antiviral drug discovery and development
